GAIN THERAPEUTICS INC (GANX) Top Institutional Shareholders
GAIN THERAPEUTICS INC (GANX) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $15.98M in GANX holdings during the latest filing period.
Marshall Wace, Llp is currently the largest disclosed institutional shareholder of GANX tracked by InsiderSet, reporting ownership valued at approximately $3.43M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $3.15M, representing an estimated loss of -8.25% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 81% of the total disclosed GANX value among the investors covered in this analysis. Major shareholders include Marshall Wace, Llp, Potomac Capital Management, Inc., Greenlight Capital, and several other long-term asset managers with concentrated positions in GAIN THERAPEUTICS INC (GANX).
This page ranks the largest institutional GANX shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
41
Total Reported Value
$15.98M
Largest Holder
Marshall Wace, Llp
Largest Position
$3.43M
Insider Transactions (90d)
0
Latest Filing Quarter
Q1 2026
New Institutional Positions
56
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Marshall Wace, Llp | 0.00% | 1,769,788 | $3,433,389 | $3,150,223 | -$283,166 | -8.25% | |
| Potomac Capital Management, Inc. | 1.71% | 1,008,600 | $1,956,684 | $1,795,308 | -$161,376 | -8.25% | |
| Greenlight Capital | David Einhorn | 0.09% | 588,410 | $1,921,158 | $1,047,370 | -$873,788 | -45.48% |
| Jones Financial Companies Lllp | 0.00% | 631,615 | $1,155,855 | $1,124,275 | -$31,580 | -2.73% | |
| Greenlight Capital | David Einhorn | 0.03% | 566,130 | $1,098,292 | $1,007,711 | -$90,581 | -8.25% |
| Geode Capital Management, Llc | 0.00% | 447,342 | $868,527 | $796,269 | -$72,258 | -8.32% | |
| Susquehanna International Group, Llp | 0.00% | 431,267 | $836,658 | $767,655 | -$69,003 | -8.25% | |
| Vanguard Capital Management Llc | 0.00% | 399,886 | $775,779 | $711,797 | -$63,982 | -8.25% | |
| Vanguard Fiduciary Trust Co | 0.00% | 229,979 | $446,159 | $409,363 | -$36,796 | -8.25% | |
| Blackrock, Inc. | 0.00% | 225,046 | $436,589 | $400,582 | -$36,007 | -8.25% | |
| Ubs Group Ag | 0.00% | 220,489 | $427,749 | $392,470 | -$35,279 | -8.25% | |
| Jane Street Group, Llc | 0.00% | 216,883 | $420,753 | $386,052 | -$34,701 | -8.25% | |
| Cresset Asset Management, Llc | 0.00% | 160,000 | $310,400 | $284,800 | -$25,600 | -8.25% | |
| State Street Corp | 0.00% | 157,537 | $305,622 | $280,416 | -$25,206 | -8.25% | |
| Morgan Stanley | 0.00% | 139,652 | $270,925 | $248,581 | -$22,344 | -8.25% | |
| Stratos Wealth Partners, Ltd. | 0.00% | 131,621 | $255,345 | $234,285 | -$21,060 | -8.25% | |
| Northern Trust Corp | 0.00% | 113,997 | $221,154 | $202,915 | -$18,239 | -8.25% | |
| Lpl Financial Llc | 0.00% | 104,251 | $202,247 | $185,567 | -$16,680 | -8.25% | |
| Prelude Capital Management, Llc | 0.01% | 35,820 | $69,491 | $63,760 | -$5,731 | -8.25% | |
| Bridgeway Capital Management, Llc | 0.00% | 30,004 | $58,208 | $53,407 | -$4,801 | -8.25% | |
| Commonwealth Equity Services, Llc | 0.00% | 29,703 | $57,620 | $52,871 | -$4,749 | -8.24% | |
| Apollon Wealth Management, Llc | 0.00% | 26,500 | $51,410 | $47,170 | -$4,240 | -8.25% | |
| Citadel Advisors Llc | 0.00% | 24,900 | $48,306 | $44,322 | -$3,984 | -8.25% | |
| Schonfeld Strategic Advisors Llc | 0.00% | 24,500 | $47,530 | $43,610 | -$3,920 | -8.25% | |
| Oliver Luxxe Assets Llc | 0.01% | 20,250 | $39,285 | $36,045 | -$3,240 | -8.25% | |
| Vanguard Global Advisers, Llc | 0.00% | 18,376 | $35,649 | $32,709 | -$2,940 | -8.25% | |
| Wealthspire Advisors, Llc | 0.00% | 16,900 | $32,786 | $30,082 | -$2,704 | -8.25% | |
| Benedict Financial Advisors Inc | 0.01% | 15,500 | $30,070 | $27,590 | -$2,480 | -8.25% | |
| Millington Financial Advisors, Llc | 0.01% | 15,000 | $29,250 | $26,700 | -$2,550 | -8.72% | |
| Wealth Enhancement Advisory Services, Llc | 0.00% | 15,556 | $28,779 | $27,690 | -$1,089 | -3.79% | |
| Simplex Trading, Llc | 0.00% | 13,439 | $26,071 | $23,921 | -$2,150 | -8.25% | |
| Kestra Advisory Services, Llc | 0.00% | 12,000 | $23,280 | $21,360 | -$1,920 | -8.25% | |
| Wells Fargo & Company/Mn | 0.00% | 11,050 | $21,437 | $19,669 | -$1,768 | -8.25% | |
| Group One Trading Llc | 0.00% | 6,404 | $12,424 | $11,399 | -$1,025 | -8.25% | |
| Tower Research Capital Llc (Trc) | 0.00% | 5,506 | $10,682 | $9,801 | -$881 | -8.25% | |
| Newedge Advisors, Llc | 0.00% | 10,600 | $10,600 | $18,868 | +$8,268 | +78.00% | |
| Cambridge Investment Research Advisors, Inc. | 0.00% | 568,645 | $1,103 | $1,012,188 | +$1,011,085 | +91666.83% | |
| Gsa Capital Partners Llp | 0.04% | 312,467 | $606 | $556,191 | +$555,585 | +91680.74% | |
| Virtu Financial Llc | 0.00% | 10,685 | $21 | $19,019 | +$18,998 | +90468.10% | |
| Larson Financial Group Llc | 0.00% | 10 | $19 | $18 | -$1 | -6.32% | |
| Citigroup Inc | 0.00% | 1 | $2 | $2 | -$0 | -11.00% |
Frequently asked questions about GANX
Who owns the most GANX stock?
The largest holders of GANX are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for GAIN THERAPEUTICS INC (GANX).
Is GANX widely held by superinvestors?
Many widely followed stocks like GANX appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly GANX is represented among the institutional managers we track.
What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?
Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.